trial · primary record
Biopsy Procedure
AIDS-Related Diffuse Large B-cell Lymphoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2028-12-01 |
| Primary endpoint | Ability to deliver at least 4 full cycles of glofitamab-rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (Glofit-RCHOP) (Feasibility) |
| Registry ID | NCT07649304 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:47.272Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07649304
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biopsy Procedure · compound